Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Locations section restructured with new regional headings and entries (California, Victoria, Estado de Bahia, Pernambuco, Rio Grande do Sul, São Paulo, Ontario, Quebec, Campania, Emilia-Romagna, Bashkortostan Republic, Madrid), and removal of the previous region-specific headers such as 'California Locations' and 'Victoria Locations'.
    Difference
    0.9%
    Check dated 2025-12-23T20:29:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The changes are minor site revision updates: v3.3.2 added and v3.2.0 removed, with no impact on study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:04:57.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The banner about lapse in government funding and NIH operating status was removed from the page. No study details or required actions for participants were affected.
    Difference
    0.2%
    Check dated 2025-11-17T18:27:49.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study details page still presents the trial overview, eligibility criteria, interventions, outcomes, and locations with no substantive additions or deletions observed.
    Difference
    0.3%
    Check dated 2025-11-03T13:10:32.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and v3.2.0 release replaces v3.1.0; informs users about potential delays and where to check current status.
    Difference
    2%
    Check dated 2025-10-06T04:14:55.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Core content sections on drug safety and related topics were removed, and a new version tag v3.1.0 was added. This indicates content consolidation and a version upgrade with less emphasis on the previously listed drug-safety topics.
    Difference
    0.2%
    Check dated 2025-09-28T23:39:04.000Z thumbnail image

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.